Provision 7130/2015, concerning the active pharmaceutical ingredient “antimicrobial activity” published in September in the Official Gazette, should be applied to the presentation of the sale of medicinal preparations registered or entered in the Register of Medical Specialties ( Registro de Especialidades Medicinales, REM). This new provision complies with Argentina´s strategy for the Control of Antimicrobial Resistance, which was approved in a joint-resolution of the Ministry of Health.
“Antimicrobial resistance” is an extremely important worldwide problem because it reduces the therapeutic action of drugs and thus their ability to attack infections and overcome diseases.
This measure adopted by the Ministry of Health of Argentina is aimed at the protection of the health of the population and outlines the presentation of such medicines and drugs by dose and the duration of the treatment according to doctor’s prescriptions.
The objective of this measure is clear: that there should be no leftover or missing units in any prescribed treatment. Currently, the number of dosage units received by pharmacies from laboratories may be critical for two reasons: a) it may be insufficient and this may cause that the patient not to complete the prescribed treatment; and/or b) it may be excessive, so the patient may use the antibiotic longer than necessary or in an uncontrolled manner, before a new alleged infection without proper consultation and medical prescription.
For more details about this new regulation, please click here
